Open AccessINVESTIGATIVE CRITIQUE OF THE PAPER ENTITLED " HYDROXYCHLOROQUINE AND AZITHROMYCIN AS A TREATMENT OF COVID-19: RESULTS OF AN OPEN-LABEL NON-RANDOMIZED CLINICAL TRIAL", AUTHORED BY GAUTRET, P., LAGIER, J.-C., PAROLA, P., HOANG, V.T., MEDDEB, L., MAILHE, M., DOUDIER, B., COURJON, J., GIORDANENGO, V., VIEIRA, V.E., TISSOT, H., HONERE, S., LA SCOLA, B., ROLAIN, J.-M., BROUQUI, P. AND RAOULT, D., AND PUBLISHED IN INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS [(INT. J. ANTIMICROB. AGENTS (2020), …
Author(s) -
H.Y. Lim Tung
Publication year - 2020
Publication title -
zenodo (cern european organization for nuclear research)
Language(s) - English
DOI - 10.5281/zenodo.4295553
Subject(s) - azithromycin , hydroxychloroquine , covid-19 , medicine , randomized controlled trial , traditional medicine , virology , outbreak , biology , microbiology and biotechnology , antibiotics , disease , infectious disease (medical specialty)